Jon Alexander Schwartz
Technik-/Wissenschafts-/F&E-Leiter bei Nanospectra Biosciences, Inc.
Profil
Jon Alexander Schwartz is currently the Director-Clinical Research at Nanospectra Biosciences, Inc. He has an undergraduate and graduate degree from Rice University and a doctorate from the University of Texas Graduate School of Biomedical Sciences.
Aktive Positionen von Jon Alexander Schwartz
| Unternehmen | Position | Beginn |
|---|---|---|
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Technik-/Wissenschafts-/F&E-Leiter | 13.06.2013 |
Ausbildung von Jon Alexander Schwartz
| Rice University | Graduate Degree |
| University of Texas Graduate School of Biomedical Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
